Literature DB >> 27893926

Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models.

Jincheng Shen1, Lu Wang2, Jeremy M G Taylor2.   

Abstract

Prostate cancer patients are closely followed after the initial therapy and salvage treatment may be prescribed to prevent or delay cancer recurrence. The salvage treatment decision is usually made dynamically based on the patient's evolving history of disease status and other time-dependent clinical covariates. A multi-center prostate cancer observational study has provided us data on longitudinal prostate specific antigen (PSA) measurements, time-varying salvage treatment, and cancer recurrence time. These data enable us to estimate the best dynamic regime of salvage treatment, while accounting for the complicated confounding of time-varying covariates present in the data. A Random Forest based method is used to model the probability of regime adherence and inverse probability weights are used to account for the complexity of selection bias in regime adherence. The optimal regime is then identified by the largest restricted mean survival time. We conduct simulation studies with different PSA trends to mimic both simple and complex regime adherence mechanisms. The proposed method can efficiently accommodate complex and possibly unknown adherence mechanisms, and it is robust to cases where the proportional hazards assumption is violated. We apply the method to data collected from the observational study and estimate the best salvage treatment regime in managing the risk of prostate cancer recurrence.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Causal inference; Dynamic treatment regime; Inverse probability weighting; Random forest; Restricted mean survival time

Mesh:

Substances:

Year:  2016        PMID: 27893926      PMCID: PMC5466876          DOI: 10.1111/biom.12621

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  18 in total

1.  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.

Authors:  Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

3.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

4.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

5.  A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis.

Authors:  Ori M Stitelman; Victor De Gruttola; Mark J van der Laan
Journal:  Int J Biostat       Date:  2012-09-18       Impact factor: 0.968

6.  Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes.

Authors:  Romain Neugebauer; Bruce Fireman; Jason A Roy; Patrick J O'Connor; Joe V Selby
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-05       Impact factor: 2.890

7.  The effect of salvage therapy on survival in a longitudinal study with treatment by indication.

Authors:  Edward H Kennedy; Jeremy M G Taylor; Douglas E Schaubel; Scott Williams
Journal:  Stat Med       Date:  2010-11-10       Impact factor: 2.373

8.  Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders.

Authors:  Susan A Murphy; David W Oslin; A John Rush; Ji Zhu
Journal:  Neuropsychopharmacology       Date:  2006-11-08       Impact factor: 7.853

9.  Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling.

Authors:  Romain Neugebauer; Bruce Fireman; Jason A Roy; Marsha A Raebel; Gregory A Nichols; Patrick J O'Connor
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

10.  Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.

Authors:  Lu Wang; Andrea Rotnitzky; Xihong Lin; Randall E Millikan; Peter F Thall
Journal:  J Am Stat Assoc       Date:  2012-06       Impact factor: 5.033

View more
  6 in total

1.  Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.

Authors:  Jincheng Shen; Lu Wang; Stephanie Daignault; Daniel E Spratt; Todd M Morgan; Jeremy M G Taylor
Journal:  J Biopharm Stat       Date:  2017-10-25       Impact factor: 1.051

2.  Step-adjusted tree-based reinforcement learning for evaluating nested dynamic treatment regimes using test-and-treat observational data.

Authors:  Ming Tang; Lu Wang; Michael A Gorin; Jeremy M G Taylor
Journal:  Stat Med       Date:  2021-09-07       Impact factor: 2.373

3.  Estimating the optimal timing of surgery by imputing potential outcomes.

Authors:  Xiaofei Chen; Daniel F Heitjan; Gerald Greil; Haekyung Jeon-Slaughter
Journal:  Stat Med       Date:  2021-10-11       Impact factor: 2.373

4.  A Framework for Treatment Decision Making at Prostate Cancer Recurrence.

Authors:  Jane M Lange; Bruce J Trock; Roman Gulati; Ruth Etzioni
Journal:  Med Decis Making       Date:  2017-05-31       Impact factor: 2.583

5.  Estimating the optimal individualized treatment rule from a cost-effectiveness perspective.

Authors:  Yizhe Xu; Tom H Greene; Adam P Bress; Brian C Sauer; Brandon K Bellows; Yue Zhang; William S Weintraub; Andrew E Moran; Jincheng Shen
Journal:  Biometrics       Date:  2020-12-09       Impact factor: 2.571

Review 6.  A scoping review of studies using observational data to optimise dynamic treatment regimens.

Authors:  Maarten J IJzerman; Julie A Simpson; Robert K Mahar; Myra B McGuinness; Bibhas Chakraborty; John B Carlin
Journal:  BMC Med Res Methodol       Date:  2021-02-22       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.